Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Tur C, Tintoré M, Horga A, Auger C, Río J, Nos C, Edo MC, Arévalo MJ, Castilló J, Rovira A, Montalban X.
Vidal-Jordana A, et al. Among authors: auger c.
Mult Scler. 2013 Aug;19(9):1175-81. doi: 10.1177/1352458512473190. Epub 2013 Jan 14.
Mult Scler. 2013.
PMID: 23319072